Natalizumab-associated complication? First case of peripheral T cell lymphoma

Acta Neuropathologica

Volumn 123, Issue 5, 2012, Pages 751-752

  Schowinsky, Jeffrey ^a   Corboy, John ^b   Vollmer, Timothy ^b   Kleinschmidt DeMasters, B K ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GLATIRAMER; NATALIZUMAB; VINCRISTINE;

ADULT; BONE MARROW BIOPSY; CANCER SURVIVAL; CASE REPORT; CONFUSION; DEMYELINATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOREACTIVITY; INJECTION SITE REACTION; LETTER; MULTIPLE SCLEROSIS; NAUSEA; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; RELAPSE; SENSORY DYSFUNCTION; SKIN DISEASE; STEM CELL TRANSPLANTATION; VERTIGO;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD3; FEMALE; HUMANS; KI-67 ANTIGEN; LYMPHOMA, T-CELL, PERIPHERAL; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84862679547     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-012-0967-7     Document Type: Letter

References (17)

1. Bergamaschi R, Montomoli C (2009) Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence? Mult Scler 15:1532-1533
2. Berger JR, Houff S (2009) Opportunistic infections and other risks with newer multiple sclerosis therapies. Ann Neurol 65:367-377
3. Clifford DB, DeLuca A, Simpson DM et al (2010) Natalizumabassociated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9:438-446
4. Fox R (2011) Advances in the management of PML: focus on natalizumab. Cleve Clin J Med 78:S33-S37
5. Ismail A, Kemp J, Sharrack B (2009) Melanoma complicating treatment with Natalizumab (Tysabri) for multiple sclerosis. J Neurol 256:1771-1772
6. Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353:369-374 (Pubitemid 41132341)
7. Kotlyar DS, Osterman MT, Diamond RH et al (2011) A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 9:36-41
8. Langer-Gould A, Atlas SW, Green AJ et al (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353:375-381 (Pubitemid 41132342)
9. Laroni A, Bedognetti M, Uccelli A et al (2011) Association of melanoma and natalizumab therapy in the Italian MS population: a second case report. Neurol Sci 32:181-182
10. Mullen JT, Vartanian TK, Atkins MB (2008) Melanoma complicating treatment with natalizumab for multiple sclerosis. N Engl J Med 358:647-648 (Pubitemid 351214309)
11. Panzara MA, Bozic C, Sandrock AW (2008) More on melanoma with transdifferentiation. N Engl J Med 359:99 (Pubitemid 351931122)
12. Polman CH, O'Connor PW, Havrdova E et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899-910
13. Schweikert A, Kremer M, Ringel F et al (2009) Primary central nervous system lymphoma in a patient treated with natalizumab. Ann Neurol 66:403-406
14. Stuve O, Wiendl H (2009) Iatrogenic immunosuppression with biologics in MS: expecting the unexpected? Neurology 73: 1346-1347
15. Van Assche G, Van Ranst M, Sciot R et al (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 353:362-368 (Pubitemid 41132340)
16. Vavricka BM, Baumberger P, Russmann S, Kullak-Ublick GA (2010) Diagnosis of melanoma under concomitant natalizumab therapy. Mult Scler 17:255-256
17. Zecca C, Nessi F, Bernasconi E, Gobbi C (2009) Ocular toxoplasmosis during natalizumab treatment. Neurology 73: 1418-1419